Regionally selective increases in μ opioid receptor density in the brains of suicide victims

Gross‐Isseroff, Ruth; Dillon, Kathryn; Israeli, Malka; Biegon, Anat

doi:10.1016/0006-8993(90)91301-v

Cited by 143 publications

(90 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, clinical and biochemical evidence of alterations of the m-opioid receptor in suicide also exists. In line with the present results, it was previously shown that the density of m-opioid receptor sites is augmented in the post-mortem brain of depressed suicides (Gross-Isseroff et al, 1990;Gabilondo et al, 1995). Moreover, treatments with antidepressant drugs induce decreases in the receptor (and associated neuropeptide) levels (Hamon et al, 1987).…”

Section: Altered Expression Of L-opioid Receptors In the Brains Of Susupporting

confidence: 92%

See 1 more Smart Citation

Increased mRNA Expression of α2A-Adrenoceptors, Serotonin Receptors and μ-Opioid Receptors in the Brains of Suicide Victims

Escribá

Ozaita

Garcı́a-Sevilla

2004

Neuropsychopharmacol

124

View full text Add to dashboard Cite

The development of new therapies for the treatment of psychiatric disorders requires an in-depth knowledge of the molecular bases underlying these pathologies, which remain largely unknown. Alterations in adrenoceptors, serotonin receptors, and other G proteincoupled receptors (GPCRs) have been associated with suicide and depression. However, to date, there is little information about mRNA expression of the GPCRs in the frontal cortex of suicide victims. Our goal was to study the expression in the brain of these receptors. For this purpose, we measured mRNA levels by RT-PCR. We found that the expressions of a 2A -adrenoceptors, 5-HT 1A , 5-HT 2A serotonin receptors, and m-opioid receptors were elevated in the post-mortem brains of these suicide victims with respect to matched controls. Moreover, in the case of a 2A -adrenoceptors (the only for which these data were available), a significant correlation was observed between the level of mRNA and protein quantified in the brain of the same subjects, indicating that protein synthesis of this receptor was not influenced by post-translational regulatory mechanisms. In addition, the degree of adrenoceptor and 5-HT receptor expressions appeared to be correlated in the brains of suicide victims and control subjects. Alterations in the expression of adrenoceptors, serotonin, and opioid receptors indicate that these signaling proteins might be related to the etiopathology of suicidal and depressive behaviors. Alternatively, such changes may represent adaptive mechanisms to compensate for other as yet unknown alterations. The results also suggest that these receptors could share common regulatory mechanisms.

show abstract

Section: Altered Expression Of L-opioid Receptors In the Brains Of Susupporting

confidence: 92%

“…Finally, m-opioid receptors have been implicated in the behavioral alterations associated with stress. Indeed, its mRNA expression is augmented in the brain of rats submitted to stress (Yamamoto et al, 2003) and its protein levels were increased in the post-mortem brains of suicides (Gross-Isseroff et al, 1990;Gabilondo et al, 1995).…”

Section: Introductionmentioning

confidence: 99%

Increased mRNA Expression of α2A-Adrenoceptors, Serotonin Receptors and μ-Opioid Receptors in the Brains of Suicide Victims

Escribá

Ozaita

Garcı́a-Sevilla

2004

Neuropsychopharmacol

124

View full text Add to dashboard Cite

show abstract

“…[59][60][61] The density of -opioid receptors has been reported to be elevated in young 62,63 but not in elderly 62 depressed suicide victims. The present study, comprising a distribution of subjects similar to the subgroup termed as old by Gross-Isseroff et al, 62 did not reveal differences in functional activity of -opioid receptors between suicide victims and controls.…”

Section: Molecular Psychiatrymentioning

confidence: 99%

Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of α2A-adrenoceptors

et al. 2002

View full text Add to dashboard Cite

“…Postmortem examination of brains of suicide victims shows endorphin depletion. 5 iii. A group of patients with treatment refractory depression and unresponsive to electroconvulsive treatment had positive response to endorphins.…”

Section: Complex Evidence Of Antidepressant and Mood Altering Propertmentioning

confidence: 99%

Opiates: Benefits and Overuse Potential

Salerian¹

2015

PPIJ

View full text Add to dashboard Cite

This study reviews opiates (endorphin agonists) in treatment of pain and addiction with specific focus on their addictive potential versus benefits. This review suggests endorphin agonists enjoy mood stabilizing and antidepressant properties and have been helpful in treatment of pain, mood and addictive disorders. The evidence is consistent with the observation that slow release opiate preparations with long elimination life do have significant immunity against overuse. Collectively the evidence suggests longacting preparations of opiates are both effective to treat pain, addiction and some mood disorders and represent low risk for overuse.

show abstract

Regionally selective increases in μ opioid receptor density in the brains of suicide victims

Cited by 143 publications

References 22 publications

Increased mRNA Expression of α2A-Adrenoceptors, Serotonin Receptors and μ-Opioid Receptors in the Brains of Suicide Victims

Increased mRNA Expression of α2A-Adrenoceptors, Serotonin Receptors and μ-Opioid Receptors in the Brains of Suicide Victims

Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of α2A-adrenoceptors

Opiates: Benefits and Overuse Potential

Contact Info

Product

Resources

About